The Immunogenicity and Safety Profile for KM-248, a Combined Measles, Mumps, and Rubella Vaccine, and Its Noninferiority to the Measles Vaccine in Healthy Japanese Children: a Phase 3 Randomized Multicenter Single-Blind Clinical Trial
Platt, Heather, Tochihara, Shinji, Oda, Yoshiaki, Ueda, Kohji
Published in Japanese Journal of Infectious Diseases (30.09.2021)
Published in Japanese Journal of Infectious Diseases (30.09.2021)
Get full text
Journal Article
Immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1, NIBRG-14) vaccine administered by intramuscular or subcutaneous injection
Ikeno, Daisuke, Kimachi, Kazuhiko, Kino, Yoichiro, Harada, Seiichi, Yoshida, Kayo, Tochihara, Shinji, Itamura, Shigeyuki, Odagiri, Takato, Tashiro, Masato, Okada, Kenji, Miyazaki, Chiaki, Ueda, Kohji
Published in Microbiology and immunology (01.02.2010)
Published in Microbiology and immunology (01.02.2010)
Get more information
Journal Article
Immunogenicity and Safety of KM-248, a Combined Measles, Mumps, and Rubella vaccine, and the Noninferiority to a Measles Vaccine in Healthy Japanese Children; Phase 3 Randomized Multicenter Single-Blind Clinical Trial
Platt, Heather, Tochihara, Shinji, Oda, Yoshiaki, Ueda, Kohji
Published in Japanese Journal of Infectious Diseases (29.01.2021)
Published in Japanese Journal of Infectious Diseases (29.01.2021)
Get full text
Journal Article
A clinical phase I study of an EB66 cell-derived H5N1 pandemic vaccine adjuvanted with AS03
Naruse, Takeshi, Fukuda, Tadashi, Tanabe, Tetsuro, Ichikawa, Munetaka, Oda, Yoshiaki, Tochihara, Shinji, Kimachi, Kazuhiko, Kino, Yoichiro, Ueda, Kohji
Published in Vaccine (09.11.2015)
Published in Vaccine (09.11.2015)
Get full text
Journal Article